Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes

Chemico-Biological Interactions

Volumn 178, Issue 1-3, 2009, Pages 317-323

  Mehta, Rhea ^a   Wong, Lilian ^b   O'Brien, Peter J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Advanced glycation end products; Carbonylation; Cytotoxicity; Diabetes; Dicarbonyls; Protein; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; AMINOGUANIDINE; CYSTEINE; GLYOXAL; HYDRALAZINE; LIPID; MANNITOL; METFORMIN; PENICILLAMINE; PYRIDOXAMINE; QUERCETIN; REACTIVE OXYGEN METABOLITE; TEMPOL; TROLOX C;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CELL ISOLATION; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; LIVER CELL; MALE; MITOCHONDRION; NONHUMAN; PROTEIN CARBONYLATION; RAT; SCAVENGING SYSTEM;

ANIMALS; CELL-FREE SYSTEM; CYTOPROTECTION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEPATOCYTES; LIPID PEROXIDATION; MALE; MEMBRANE POTENTIALS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 59049105100     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.10.026     Document Type: Article

References (57)

1. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabet. Res. Clin. Pract. 67 (2005) 3-21
2. Manini P., La Pietra P., Panzella L., Napolitano A., and d'Ischia M. Glyoxal formation by Fentoninduced degradation of carbohydrates and related compounds. Carbohydr. Res 341 (2006) 1828-1833
3. Cejpek K., Velíšek J., and Novotný O. Formation of a-hydroxycarbonyl and a-dicarbonyl compounds during degradation of monosaccharides. Czech J. Food Sci. 25 (2007) 119-130
4. Usui T., Yanagisawa S., Ohguchi M., Yoshino M., Kawabata R., Kishimoto J., Arai Y., Aida K., Watanabe H., and Hayase F. Identification and determination of alpha-dicarbonyl compounds formed in the degradation of sugars. Biosci. Biotechnol. Biochem. 71 (2007) 2465-2472
5. Voziyan P.A., Metz T.O., Baynes J.W., and Hudson B.G. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J. Biol. Chem. 277 (2002) 3397-3403
6. Thornalley P.J., Langborg A., and Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 344 Pt 1 (1999) 109-116
7. Abordo E.A., Minhas H.S., and Thornalley P.J. Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem. Pharmacol. 58 (1999) 641-648
8. Chen A.S., Taguchi T., Sugiura M., Wakasugi Y., Kamei A., Wang M.W., and Miwa I. Pyridoxalaminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats. Horm. Metab. Res. 36 (2004) 183-187
9. Peyroux J., and Sternberg M. Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathol. Biol. (Paris) 54 (2006) 405-419
10. Thornalley P.J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 419 (2003) 31-40
11. Thornalley P.J., Yurek-George A., and Argirov O.K. Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem. Pharmacol. 60 (2000) 55-65
12. Kiho T., Kato M., Usui S., and Hirano K. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal. Clin. Chim. Acta 358 (2005) 139-145
13. Ruggiero-Lopez D., Lecomte M., Moinet G., Patereau G., Lagarde M., and Wiernsperger N. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem. Pharmacol. 58 (1999) 1765-1773
14. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174
15. Burcham P.C., and Pyke S.M. Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection. Mol. Pharmacol. 69 (2006) 1056-1065
16. Kaminskas L.M., Pyke S.M., and Burcham P.C. Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice. J. Pharmacol. Exp. Ther. 310 (2004) 1003-1010
17. Mehta R., and O'Brien P.J. Therapeutic intracellular targets for preventing carbonyl cell death with B vitamins or drugs. Enzymology and Molecular Biology of Carbonyl Metabolism. 13th ed. (2007) pp. 113-120
18. Nangaku M., Miyata T., Sada T., Mizuno M., Inagi R., Ueda Y., Ishikawa N., Yuzawa H., Koike H., van Ypersele d.S., and Kurokawa K. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. J. Am. Soc. Nephrol. 14 (2003) 1212-1222
19. Negre-Salvayre A., Coatrieux C., Ingueneau C., and Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 153 (2008) 6-20
20. Nagaraj R.H., Sarkar P., Mally A., Biemel K.M., Lederer M.O., and Padayatti P.S. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch. Biochem. Biophys. 402 (2002) 110-119
21. Babaei-Jadidi R., Karachalias N., Ahmed N., Battah S., and Thornalley P.J. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52 (2003) 2110-2120
22. Stitt A., Gardiner T.A., Alderson N.L., Canning P., Frizzell N., Duffy N., Boyle C., Januszewski A.S., Chachich M., Baynes J.W., and Thorpe S.R. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51 (2002) 2826-2832
23. Voziyan P.A., and Hudson B.G. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage. Cell Mol. Life Sci. 62 (2005) 1671-1681
24. Chetyrkin S.V., Zhang W., Hudson B.G., Serianni A.S., and Voziyan P.A. Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: mechanism of action of pyridoxamine. Biochemistry 47 (2008) 997-1006
25. Chang K., Uitto J., Rowold E.A., Grant G.A., Kilo C., and Williamson J.R. Increased collagen cross-linkages in experimental diabetes: reversal by beta-aminopropionitrile and d-penicillamine. Diabetes 29 (1980) 778-781
26. Wondrak G.T., Cervantes-Laurean D., Roberts M.J., Qasem J.G., Kim M., Jacobson E.L., and Jacobson M.K. Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem. Pharmacol. 63 (2002) 361-373
27. Yoshida Y., Furuta S., and Niki E. Effects of metal chelating agents on the oxidation of lipids induced by copper and iron. Biochim. Biophys. Acta 1210 (1993) 81-88
28. De Flora S., Izzotti A., D'Agostini F., and Balansky R.M. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22 (2001) 999-1013
29. Thong-Ngam D., Samuhasaneeto S., Kulaputana O., and Klaikeaw N. N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis. World J. Gastroenterol. 13 (2007) 5127-5132
30. Fu A.L., Dong Z.H., and Sun M.J. Protective effect of N-acetyl-l-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice. Brain Res. 1109 (2006) 201-206
31. Hirayama C., Kishimoto Y., Wakushima T., and Murawaki Y. Mechanism of the protective action of thiol compounds in ethanol-induced liver injury. Biochem. Pharmacol. 32 (1983) 321-325
32. Moldeus P., Hogberg J., and Orrenius S. Isolation and use of liver cells. Methods Enzymol. 52 (1978) 60-71
33. Moridani M.Y., Pourahmad J., Bui H., Siraki A., and O'Brien P.J. Dietary flavonoid iron complexes as cytoprotective superoxide radical scavengers. Free Radic. Biol. Med. 34 (2003) 243-253
34. Possel H., Noack H., Augustin W., Keilhoff G., and Wolf G. 2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Lett. 416 (1997) 175-178
35. 2+. Toxicology 143 (2000) 263-273
36. Bagchi D., Carryl O.R., Tran M.X., Krohn R.L., Bagchi D.J., and Garg A. Stress, diet and alcohol-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate. J. Appl. Toxicol. 18 (1998) 3-13
37. Nash T. The colirometric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55 (1953) 416-421
38. Winters D.K., and Cederbaum A.I. Oxidation of glycerol to formaldehyde by rat liver microsomes Effects of cytochrome P-450 inducing agents. Biochem. Pharmacol. 39 (1990) 697-705
39. Hartley D.P., Kroll D.J., and Petersen D.R. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem. Res. Toxicol. 10 (1997) 895-905
40. Andersson B.S., Aw T.Y., and Jones D.P. Mitochondrial transmembrane potential and pH gradient during anoxia. Am. J. Physiol. 252 (1987) C349-C355
41. Mitchel R.E., and Birnboim H.C. The use of Girard-T reagent in a rapid and sensitive methods for measuring glyoxal and certain other alpha-dicarbonyl compounds. Anal. Biochem. 81 (1977) 47-56
42. Depeint F., Bruce W.R., Shangari N., Mehta R., and O'Brien P.J. Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem. Biol. Interact. 163 (2006) 113-132
43. Requena J.R., Levine R.L., and Stadtman E.R. Recent advances in the analysis of oxidized proteins. Amino Acids 25 (2003) 221-226
44. Stadtman E.R., and Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab. Rev. 30 (1998) 225-243
45. Munzel T., Kurz S., Rajagopalan S., Thoenes M., Berrington W.R., Thompson J.A., Freeman B.A., and Harrison D.G. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. J. Clin. Invest. 98 (1996) 1465-1470
46. Price D.L., Rhett P.M., Thorpe S.R., and Baynes J.W. Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem. 276 (2001) 48967-48972
47. Brown B.E., Mahroof F.M., Cook N.L., van Reyk D.M., and Davies M.J. Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins. Diabetologia 49 (2006) 775-783
48. Jedidi I., Therond P., Zarev S., Cosson C., Couturier M., Massot C., Jore D., Gardes-Albert M., Legrand A., and Bonnefont-Rousselot D. Paradoxical protective effect of aminoguanidine toward low-density lipoprotein oxidation: inhibition of apolipoprotein B fragmentation without preventing its carbonylation. Mechanism of action of aminoguanidine. Biochemistry 42 (2003) 11356-11365
49. Fu M.X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thorpe S.R., and Baynes J.W. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43 (1994) 676-683
50. Kanigur-Sultuybek G., Ozdas S.B., Curgunlu A., Tezcan V., and Onaran I. Does metformin prevent short-term oxidant-induced dna damage? In vitro study on lymphocytes from aged subjects. J. Basic Clin. Physiol. Pharmacol. 18 (2007) 129-140
51. Bonnefont-Rousselot D., Raji B., Walrand S., Gardes-Albert M., Jore D., Legrand A., Peynet J., and Vasson M.P. An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 52 (2003) 586-589
52. Ouslimani N., Peynet J., Bonnefont-Rousselot D., Therond P., Legrand A., and Beaudeux J.L. Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism 54 (2005) 829-834
53. Mehta R., Shangari N., and O'Brien P.J. Preventing cell death induced by carbonyl stress, oxidative stress or mitochondrial toxins with vitamin B anti-AGE agents. Mol. Nutr. Food Res. 52 (2008) 379-385
54. 2-treated U937 monocytes. Free Radic. Biol. Med. 36 (2004) 423-428
55. Schauenstein E., Zollner H., and Esterbauer H. Aldehydes in Biological Systems: Their Natural Occurrence and Biological Activities (1977), Pion Press, London pp. 163-171
56. Vasdev S., Ford C.A., Longerich L., Gadag V., and Wadhawan S. Role of aldehydes in fructose induced hypertension. Mol. Cell Biochem. 181 (1998) 1-9
57. Shangari N., and O'Brien P.J. The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem. Pharmacol. 68 (2004) 1433-1442